medRxiv PreprintsInternational20 November 2026
Loss of contractile arteriolar smooth muscle cells and their GLP1R expression in human diabetic kidney disease
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Glucagon-like peptide-1 (GLP-1) receptor agonists slow kidney disease progression in type 2 diabetes, and in the human kidney the receptor is localized mainly to arteriolar smooth muscle. Whether these cells and their receptor are preserved in diabetic kidney disease (DKD) is unknown. We combined single-cell-level spatial transcriptomics of 5,101 genes with registered periodic acid-Schiff histology in kidney biopsies from 28 people with DKD, 102 with other glomerular diseases and 24 living donors, and measured 2,531 arterioles and small arteries. Arteriolar walls in DKD contained about 20% few
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.